FDA Approved: TOREMIFENE CITRATE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Rising Pharma Holdings' generic toremifene citrate (ANDA 208813) for the treatment of breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Toremifene citrate (toremifene citrate)

Snippet

ORIG AP for TOREMIFENE CITRATE (TOREMIFENE CITRATE)